{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:58Z","timestamp":1791357538012,"version":"4.3.1"},"reference-count":41,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Aust N Z J Psychiatry"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In most countries, clozapine can only be prescribed with regular monitoring of white blood cell counts because of concerns that clozapine has a stronger association with neutropenia than other antipsychotics. However, this has not been previously demonstrated conclusively with meta-analysis of controlled studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The aim of this study was to assess the strength of the association between clozapine and neutropenia when compared to other antipsychotic medications by a meta-analysis of controlled studies. An electronic search of Medline (1948\u20132018), PsycINFO (1967\u20132018) and Embase (1947\u20132018) using search terms (clozapine OR clopine OR clozaril OR zaponex) AND (neutropenia OR agranulocytosis) was undertaken. Random-effects meta-analysis using Mantel\u2013Haenszel risk ratio was used to assess the strength of the effect size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We located 20 studies that reported rates of neutropenia associated with clozapine and other antipsychotic medications. The risk ratio was not significantly increased in clozapine-exposed groups compared to exposure to other antipsychotic medications (Mantel\u2013Haenszel risk ratio\u2009=\u20091.45, 95% confidence interval = [0.87, 2.42]). This also applied to severe neutropenia (absolute neutrophil count\u2009&lt;\u2009500 per \u00b5L) when compared to other antipsychotics (Mantel\u2013Haenszel risk ratio = 1.65, 95% confidence interval = [0.58, 4.71]). The relative risk of neutropenia associated with clozapine exposure was not significantly associated with any individual antipsychotic medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Data from controlled trials do not support the belief that clozapine has a stronger association with neutropenia than other antipsychotic medications. This implies that either all antipsychotic drugs should be subjected to haematological monitoring or monitoring isolated to clozapine is not justified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0004867419833166","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T08:07:47Z","timestamp":1552464467000},"page":"403-412","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":77,"title":["A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia"],"prefix":"10.1177","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-581X","authenticated-orcid":false,"given":"Nicholas","family":"Myles","sequence":"first","affiliation":[{"name":"Division of Haematology, SA Pathology, Adelaide, SA, Australia"},{"name":"School of Medicine, The University of Queensland, St Lucia, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Myles","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Prince of Wales Hospital, Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Large","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Prince of Wales Hospital, Kensington, NSW, Australia"},{"name":"School of Psychiatry, UNSW Sydney, Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bird","sequence":"additional","affiliation":[{"name":"Division of Cancer Services, Princess Alexandra Hospital, Woolloongabba, QLD, Australia"},{"name":"School of Medicine, Griffith University, Nathan, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherrie","family":"Galletly","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia"},{"name":"Mental Health, Ramsay Health Care, Gilberton, SA, Australia"},{"name":"Department of Mental Health, Northern Adelaide Local Health Network, Elizabeth, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4021-2924","authenticated-orcid":false,"given":"Steve","family":"Kisely","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Queensland, St Lucia, QLD, Australia"},{"name":"Departments of Psychiatry, Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Siskind","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Queensland, St Lucia, QLD, Australia"},{"name":"Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"bibr1-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"bibr2-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00224.x"},{"key":"bibr3-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"bibr4-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1305"},{"key":"bibr5-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.4.499"},{"key":"bibr6-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2018-102911"},{"key":"bibr7-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.06.068"},{"key":"bibr8-0004867419833166","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.155.6.855a","volume":"155","author":"Finkel B","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"bibr9-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.081471"},{"key":"bibr10-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800503"},{"key":"bibr11-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199705000-00001"},{"key":"bibr12-0004867419833166","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0109"},{"key":"bibr13-0004867419833166","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-7-200704030-00004"},{"key":"bibr14-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606409"},{"key":"bibr15-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1167-0"},{"key":"bibr16-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"bibr17-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830120020005"},{"key":"bibr18-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.043"},{"key":"bibr19-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu001"},{"key":"bibr20-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.600"},{"key":"bibr21-0004867419833166","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464070-00003"},{"key":"bibr22-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.02.018"},{"key":"bibr23-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000236769.31279.19"},{"key":"bibr24-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0050"},{"key":"bibr25-0004867419833166","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"bibr26-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800306"},{"key":"bibr27-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576"},{"key":"bibr28-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12898"},{"key":"bibr29-0004867419833166","unstructured":"National Cancer Institute (2009) Common terminology criteria for adverse events v4.0. Report for the National Institutes of Health, publication no. 09-7473, 28 May. Bethesda, MD: National Cancer Institute."},{"key":"bibr30-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0311-1"},{"key":"bibr31-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709183371202"},{"key":"bibr32-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1300\/J079v21n04_02"},{"key":"bibr33-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2001.00429.x"},{"key":"bibr34-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1080\/03610919608813357"},{"key":"bibr35-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.7.721"},{"key":"bibr36-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.177261"},{"key":"bibr37-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1761"},{"key":"bibr38-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01026-X"},{"key":"bibr39-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.2.255"},{"key":"bibr40-0004867419833166","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(00)00118-4"},{"key":"bibr41-0004867419833166","unstructured":"Wells GA, Shea BO\u2019, connell D, et al. (2009) The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (accessed 3 July 2017)."}],"container-title":["Australian &amp; New Zealand Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0004867419833166","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0004867419833166","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0004867419833166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:57:00Z","timestamp":1777373820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0004867419833166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1177\/0004867419833166"],"URL":"https:\/\/doi.org\/10.1177\/0004867419833166","relation":{},"ISSN":["0004-8674","1440-1614"],"issn-type":[{"value":"0004-8674","type":"print"},{"value":"1440-1614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}